RTS,S (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "RTS,S" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

15doi.org

2^nd place

6who.int

195^th place

302^nd place

4semanticscholar.org

11^th place

8^th place

4web.archive.org

1^st place

1europa.eu

68^th place

117^th place

1youtube.com

9^th place

13^th place

1npr.org

92^nd place

72^nd place

1unicef.org

1,791^st place

1,568^th place

1science.org

1,160^th place

737^th place

1google.com

163^rd place

185^th place

1unl.edu

1,708^th place

1,051^st place

1worksinprogress.co

low place

1zenodo.org

621^st place

380^th place

1gizmag.com

7,208^th place

4,661^st place

1gsk.com

low place

1reuters.com

49^th place

47^th place

1bbc.com

20^th place

30^th place

1theguardian.com

12^th place

11^th place

1nytimes.com

7^th place

1harvard.edu

18^th place

17^th place

bbc.com

Walsh F (24 July 2015). "Malaria vaccine gets 'green light'". BBC News. Archived from the original on 21 July 2020. Retrieved 25 July 2015.

doi.org

Hill AV (October 2011). "Vaccines against malaria". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 366 (1579): 2806–2814. doi:10.1098/rstb.2011.0091. PMC 3146776. PMID 21893544.
Graves P, Gelband H (April 2006). Graves PM (ed.). "Vaccines for preventing malaria (SPf66)". The Cochrane Database of Systematic Reviews. 2006 (2): CD005966. doi:10.1002/14651858.CD005966. PMC 6532709. PMID 16625647.
Graves P, Gelband H (October 2006). Graves PM (ed.). "Vaccines for preventing malaria (blood-stage)". The Cochrane Database of Systematic Reviews. 2006 (4): CD006199. doi:10.1002/14651858.CD006199. PMC 6532641. PMID 17054281.
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al. (March 2005). "Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research". Vaccine. 23 (17–18): 2243–2250. doi:10.1016/j.vaccine.2005.01.142. PMID 15755604. S2CID 22824901. Archived from the original on 23 July 2018.
Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, et al. (January 2014). "Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection". The Journal of Clinical Investigation. 124 (1): 140–144. doi:10.1172/JCI70349. PMC 3871238. PMID 24292709.
Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al. (December 2012). "A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants". The New England Journal of Medicine. 367 (24): 2284–2295. doi:10.1056/NEJMoa1208394. PMC 10915853. PMID 23136909.
Regules JA, Cummings JF, Ockenhouse CF (May 2011). "The RTS,S vaccine candidate for malaria". Expert Review of Vaccines. 10 (5): 589–599. doi:10.1586/erv.11.57. PMID 21604980. S2CID 20443829.
Greenwood B, Doumbo OK (January 2016). "Implementation of the malaria candidate vaccine RTS,S/AS01". Lancet. 387 (10016). London, England: 318–319. doi:10.1016/S0140-6736(15)00807-7. PMID 26549465.
Devi S (July 2023). "12 countries to get first doses of malaria vaccine". Lancet. 402 (10397): 172. doi:10.1016/s0140-6736(23)01456-3. PMID 37454658. S2CID 259849056.
Rutgers T, Gordon D, Gathoye AM, Hollingdale M, Hockmeyer W, Rosenberg M, De Wilde M (September 1988). "Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum". Nature Biotechnology. 6 (9): 1065–1070. doi:10.1038/nbt0988-1065. S2CID 39880644.
RTS, S Clinical Trials Partnership (July 2015). "Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial". Lancet. 386 (9988): 31–45. doi:10.1016/S0140-6736(15)60721-8. PMC 5626001. PMID 25913272.
Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, et al. (April 2016). "Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics". PLOS Pathogens. 12 (4): e1005606. doi:10.1371/journal.ppat.1005606. PMC 4851412. PMID 27128092.
Lopaticki S, Yang AS, John A, Scott NE, Lingford JP, O'Neill MT, et al. (September 2017). "Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts". Nature Communications. 8 (1): 561. Bibcode:2017NatCo...8..561L. doi:10.1038/s41467-017-00571-y. PMC 5601480. PMID 28916755.
Swearingen KE, Lindner SE, Flannery EL, Vaughan AM, Morrison RD, Patrapuvich R, et al. (July 2017). "Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites". PLOS Neglected Tropical Diseases. 11 (7): e0005791. doi:10.1371/journal.pntd.0005791. PMC 5552340. PMID 28759593.
Goddard-Borger ED, Boddey JA (May 2018). "Implications of Plasmodium glycosylation on vaccine efficacy and design". Future Microbiology. 13 (6): 609–612. doi:10.2217/fmb-2017-0284. PMID 29624074.

europa.eu

ema.europa.eu

"Mosquirix H-W-2300". European Medicines Agency (EMA). 8 December 2020. Retrieved 4 March 2021.

gizmag.com

Borghino D (27 April 2015). "Malaria vaccine candidate shown to prevent thousands of cases". www.gizmag.com. Retrieved 11 June 2016.

google.com

"HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG".

gsk.com

"GSK announces EU regulatory submission of malaria vaccine candidate RTS,S" (Press release). GSK. 24 July 2014. Archived from the original on 4 December 2016. Retrieved 30 July 2015.

harvard.edu

ui.adsabs.harvard.edu

Lopaticki S, Yang AS, John A, Scott NE, Lingford JP, O'Neill MT, et al. (September 2017). "Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts". Nature Communications. 8 (1): 561. Bibcode:2017NatCo...8..561L. doi:10.1038/s41467-017-00571-y. PMC 5601480. PMID 28916755.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hill AV (October 2011). "Vaccines against malaria". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 366 (1579): 2806–2814. doi:10.1098/rstb.2011.0091. PMC 3146776. PMID 21893544.
Graves P, Gelband H (April 2006). Graves PM (ed.). "Vaccines for preventing malaria (SPf66)". The Cochrane Database of Systematic Reviews. 2006 (2): CD005966. doi:10.1002/14651858.CD005966. PMC 6532709. PMID 16625647.
Graves P, Gelband H (October 2006). Graves PM (ed.). "Vaccines for preventing malaria (blood-stage)". The Cochrane Database of Systematic Reviews. 2006 (4): CD006199. doi:10.1002/14651858.CD006199. PMC 6532641. PMID 17054281.
Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al. (March 2005). "Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research". Vaccine. 23 (17–18): 2243–2250. doi:10.1016/j.vaccine.2005.01.142. PMID 15755604. S2CID 22824901. Archived from the original on 23 July 2018.
Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, et al. (January 2014). "Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection". The Journal of Clinical Investigation. 124 (1): 140–144. doi:10.1172/JCI70349. PMC 3871238. PMID 24292709.
Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al. (December 2012). "A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants". The New England Journal of Medicine. 367 (24): 2284–2295. doi:10.1056/NEJMoa1208394. PMC 10915853. PMID 23136909.
Regules JA, Cummings JF, Ockenhouse CF (May 2011). "The RTS,S vaccine candidate for malaria". Expert Review of Vaccines. 10 (5): 589–599. doi:10.1586/erv.11.57. PMID 21604980. S2CID 20443829.
Greenwood B, Doumbo OK (January 2016). "Implementation of the malaria candidate vaccine RTS,S/AS01". Lancet. 387 (10016). London, England: 318–319. doi:10.1016/S0140-6736(15)00807-7. PMID 26549465.
Devi S (July 2023). "12 countries to get first doses of malaria vaccine". Lancet. 402 (10397): 172. doi:10.1016/s0140-6736(23)01456-3. PMID 37454658. S2CID 259849056.
RTS, S Clinical Trials Partnership (July 2015). "Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial". Lancet. 386 (9988): 31–45. doi:10.1016/S0140-6736(15)60721-8. PMC 5626001. PMID 25913272.
Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, et al. (April 2016). "Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics". PLOS Pathogens. 12 (4): e1005606. doi:10.1371/journal.ppat.1005606. PMC 4851412. PMID 27128092.
Lopaticki S, Yang AS, John A, Scott NE, Lingford JP, O'Neill MT, et al. (September 2017). "Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts". Nature Communications. 8 (1): 561. Bibcode:2017NatCo...8..561L. doi:10.1038/s41467-017-00571-y. PMC 5601480. PMID 28916755.
Swearingen KE, Lindner SE, Flannery EL, Vaughan AM, Morrison RD, Patrapuvich R, et al. (July 2017). "Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites". PLOS Neglected Tropical Diseases. 11 (7): e0005791. doi:10.1371/journal.pntd.0005791. PMC 5552340. PMID 28759593.
Goddard-Borger ED, Boddey JA (May 2018). "Implications of Plasmodium glycosylation on vaccine efficacy and design". Future Microbiology. 13 (6): 609–612. doi:10.2217/fmb-2017-0284. PMID 29624074.

ncbi.nlm.nih.gov

Hill AV (October 2011). "Vaccines against malaria". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 366 (1579): 2806–2814. doi:10.1098/rstb.2011.0091. PMC 3146776. PMID 21893544.
Graves P, Gelband H (April 2006). Graves PM (ed.). "Vaccines for preventing malaria (SPf66)". The Cochrane Database of Systematic Reviews. 2006 (2): CD005966. doi:10.1002/14651858.CD005966. PMC 6532709. PMID 16625647.
Graves P, Gelband H (October 2006). Graves PM (ed.). "Vaccines for preventing malaria (blood-stage)". The Cochrane Database of Systematic Reviews. 2006 (4): CD006199. doi:10.1002/14651858.CD006199. PMC 6532641. PMID 17054281.
Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, et al. (January 2014). "Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection". The Journal of Clinical Investigation. 124 (1): 140–144. doi:10.1172/JCI70349. PMC 3871238. PMID 24292709.
Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al. (December 2012). "A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants". The New England Journal of Medicine. 367 (24): 2284–2295. doi:10.1056/NEJMoa1208394. PMC 10915853. PMID 23136909.
RTS, S Clinical Trials Partnership (July 2015). "Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial". Lancet. 386 (9988): 31–45. doi:10.1016/S0140-6736(15)60721-8. PMC 5626001. PMID 25913272.
Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, et al. (April 2016). "Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics". PLOS Pathogens. 12 (4): e1005606. doi:10.1371/journal.ppat.1005606. PMC 4851412. PMID 27128092.
Lopaticki S, Yang AS, John A, Scott NE, Lingford JP, O'Neill MT, et al. (September 2017). "Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts". Nature Communications. 8 (1): 561. Bibcode:2017NatCo...8..561L. doi:10.1038/s41467-017-00571-y. PMC 5601480. PMID 28916755.
Swearingen KE, Lindner SE, Flannery EL, Vaughan AM, Morrison RD, Patrapuvich R, et al. (July 2017). "Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites". PLOS Neglected Tropical Diseases. 11 (7): e0005791. doi:10.1371/journal.pntd.0005791. PMC 5552340. PMID 28759593.

npr.org

"First malaria vaccine hits 1 million dose milestone — although it has its shortcomings". NPR. 13 May 2022. Retrieved 2 January 2023.

nytimes.com

Mandavilli A (6 October 2021). "A 'Historical Event': First Malaria Vaccine Approved by W.H.O." New York Times. Retrieved 6 October 2021.

reuters.com

Kelland K (7 October 2013). "GSK aims to market world's first malaria vaccine". Reuters. Retrieved 9 December 2013.

science.org

Wadman M (24 October 2023). "First malaria vaccine slashes early childhood mortality". Science.

semanticscholar.org

api.semanticscholar.org

Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al. (March 2005). "Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research". Vaccine. 23 (17–18): 2243–2250. doi:10.1016/j.vaccine.2005.01.142. PMID 15755604. S2CID 22824901. Archived from the original on 23 July 2018.
Regules JA, Cummings JF, Ockenhouse CF (May 2011). "The RTS,S vaccine candidate for malaria". Expert Review of Vaccines. 10 (5): 589–599. doi:10.1586/erv.11.57. PMID 21604980. S2CID 20443829.
Devi S (July 2023). "12 countries to get first doses of malaria vaccine". Lancet. 402 (10397): 172. doi:10.1016/s0140-6736(23)01456-3. PMID 37454658. S2CID 259849056.
Rutgers T, Gordon D, Gathoye AM, Hollingdale M, Hockmeyer W, Rosenberg M, De Wilde M (September 1988). "Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum". Nature Biotechnology. 6 (9): 1065–1070. doi:10.1038/nbt0988-1065. S2CID 39880644.

theguardian.com

Davies L (6 October 2021). "WHO endorses use of world's first malaria vaccine in Africa". The Guardian. Retrieved 6 October 2021.

unicef.org

"Millions more children to benefit from malaria vaccine as UNICEF secures supply". UNICEF. 16 August 2022. Retrieved 2 January 2023.

unl.edu

digitalcommons.unl.edu

Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al. (March 2005). "Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research". Vaccine. 23 (17–18): 2243–2250. doi:10.1016/j.vaccine.2005.01.142. PMID 15755604. S2CID 22824901. Archived from the original on 23 July 2018.

web.archive.org

Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, et al. (March 2005). "Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research". Vaccine. 23 (17–18): 2243–2250. doi:10.1016/j.vaccine.2005.01.142. PMID 15755604. S2CID 22824901. Archived from the original on 23 July 2018.
"GSK announces EU regulatory submission of malaria vaccine candidate RTS,S" (Press release). GSK. 24 July 2014. Archived from the original on 4 December 2016. Retrieved 30 July 2015.
Walsh F (24 July 2015). "Malaria vaccine gets 'green light'". BBC News. Archived from the original on 21 July 2020. Retrieved 25 July 2015.
Stewart S (23 October 2015). "Pilot implementation of first malaria vaccine recommended by WHO advisory groups" (Press release). Geneva: World Health Organization. Archived from the original on 19 September 2021.

who.int

"18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF".
Stewart S (23 October 2015). "Pilot implementation of first malaria vaccine recommended by WHO advisory groups" (Press release). Geneva: World Health Organization. Archived from the original on 19 September 2021.
Alonso P (19 June 2019). "Letter to partners – June 2019" (Press release). Wuxi: World Health Organization. Retrieved 22 October 2019.
Drysdale C, Kelleher K. "WHO recommends groundbreaking malaria vaccine for children at risk" (Press release). Geneva: World Health Organization. Retrieved 6 October 2021.
"Q&A on RTS,S malaria vaccine - WHO". World Health Organization. 19 April 2023. Retrieved 29 April 2023.

afro.who.int

"Malaria vaccine launched in Kenya: Kenya joins Ghana and Malawi to roll out landmark vaccine in pilot introduction" (Press release). Homa Bay: World Health Organization. 13 September 2019. Retrieved 22 October 2019.

worksinprogress.co

"Why we didn't get a malaria vaccine sooner - Works in Progress". worksinprogress.co. Retrieved 28 October 2023.

youtube.com

"RTS,S Malaria Vaccine: 2019 Partnership Award Honoree". YouTube. Global Health Technologies Coalition. Retrieved 6 October 2021.

zenodo.org

Regules JA, Cummings JF, Ockenhouse CF (May 2011). "The RTS,S vaccine candidate for malaria". Expert Review of Vaccines. 10 (5): 589–599. doi:10.1586/erv.11.57. PMID 21604980. S2CID 20443829.